Edwards Lifesciences ROE - Return on Equity 2010-2024 | EW

Edwards Lifesciences return on equity for the quarter ending June 30, 2024 was 20.94.

  • Edwards Lifesciences average return on equity for 2023 was 22.98, a 10.51% decline from 2022.
  • Edwards Lifesciences average return on equity for 2022 was 25.68, a 6.04% decline from 2021.
  • Edwards Lifesciences average return on equity for 2021 was 27.33, a 24.97% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Edwards Lifesciences ROE - Return on Equity 2010-2024 | EW

  • Edwards Lifesciences average return on equity for 2023 was 22.98, a 10.51% decline from 2022.
  • Edwards Lifesciences average return on equity for 2022 was 25.68, a 6.04% decline from 2021.
  • Edwards Lifesciences average return on equity for 2021 was 27.33, a 24.97% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.